成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

1-β-D-Ribofuranosyl-1,3,5-triazine-2,4(1H,3H)-dione

1-β-D-Ribofuranosyl-1,3,5-triazine-2,4(1H,3H)-dione Struktur
1476-82-0
CAS-Nr.
1476-82-0
Englisch Name:
1-β-D-Ribofuranosyl-1,3,5-triazine-2,4(1H,3H)-dione
Synonyma:
5-Azauridine;1-β-D-Ribofuranosyl-1,3,5-triazine-2,4(1H,3H)-dione;1,3,5-Triazine-2,4(1H,3H)-dione, 1-β-D-ribofuranosyl-;1,3,5-Triazine-2,4(1H,3H)-dione, 1-b-D-ribofuranosyl-;1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazine-2,4(1H,3H)-dione
CBNumber:
CB32313062
Summenformel:
C8H11N3O6
Molgewicht:
245.19
MOL-Datei:
1476-82-0.mol

1-β-D-Ribofuranosyl-1,3,5-triazine-2,4(1H,3H)-dione Eigenschaften

Sicherheit

1-β-D-Ribofuranosyl-1,3,5-triazine-2,4(1H,3H)-dione Chemische Eigenschaften,Einsatz,Produktion Methoden

1-β-D-Ribofuranosyl-1,3,5-triazine-2,4(1H,3H)-dione Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-β-D-Ribofuranosyl-1,3,5-triazine-2,4(1H,3H)-dione Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences 		16314854226; +16314854226
 inquiry@bocsci.com United States 19741 58
NewCan Biotech Limited 		+86-0571-86912261 +8613735419629
 sales@newcanbio.com China 9982 58
BOC Sciences 16314854226
 inquiry@bocsci.com United States 9713 58
Hangzhou FuRun Pharmaceutical Technology Co., Ltd 15658004993
 1900830611@qq.com China 965 58
NewCan Biotech Limited +86-0571-86912261 +86-15658003402
 sales@newcanbio.com China 356 58
Bide Pharmatech Ltd. 400-1647117 13681763483
 product02@bidepharm.com China 62075 58
Carbosynth --
 sales@carbosynth.com United Kingdom 6005 58
  • 1-β-D-Ribofuranosyl-1,3,5-triazine-2,4(1H,3H)-dione
  • 5-Azauridine
  • 1,3,5-Triazine-2,4(1H,3H)-dione, 1-b-D-ribofuranosyl-
  • 1,3,5-Triazine-2,4(1H,3H)-dione, 1-β-D-ribofuranosyl-
  • 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazine-2,4(1H,3H)-dione
  • 1476-82-0
Copyright 2019 ? ChemicalBook. All rights reserved